BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18688181)

  • 1. [One point message of PG-MARJ 2005 (Allergic Rhinitis) treatment of Japanese cedar pollinosis].
    Konno A
    Arerugi; 2008 Jul; 57(7):817-23. PubMed ID: 18688181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
    Ohashi Y
    Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management and treatment of pollinosis in clinic].
    Okubo K; Gotoh M
    Nihon Rinsho; 2005 May; 63 Suppl 5():145-50. PubMed ID: 15954341
    [No Abstract]   [Full Text] [Related]  

  • 5. Severity assessment of Japanese cedar pollinosis using the practical guideline for the management of allergic rhinitis in Japan and the allergic rhinitis and its impact on asthma guideline.
    Gotoh M; Yuta A; Okano M; Ohta N; Matsubara A; Okubo K
    Allergol Int; 2013 Jun; 62(2):181-9. PubMed ID: 23435559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of the difference in the pollen count on medical costs in an allergen-specific immunotherapy for Japanese cedar pollinosis].
    Yuta A; Miyamoto Y; Hattori R; Ogihara H; Takeuchi K; Majima Y
    Arerugi; 2007 Nov; 56(11):1366-71. PubMed ID: 18059149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
    Tofukuji S; Ishida S; Katayama K
    Nihon Yakurigaku Zasshi; 2017; 150(2):68-71. PubMed ID: 28794300
    [No Abstract]   [Full Text] [Related]  

  • 8. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The evaluation of hyposensitization with sugi pollen extracts in patients with nasal allergy to Japanese sugi pollen].
    Ukai K; Amesara R; Masuda S; Nakamato S; Ohkawa C; Okamoto K; Sakakura Y
    Arerugi; 1994 Feb; 43(2 Pt 1):101-5. PubMed ID: 8147711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
    Horiguchi S; Tanaka Y; Uchida T; Chazono H; Ookawa T; Sakurai D; Okamoto Y
    Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The enhanced clinical efficacy by treated years and the sustained efficacy after treatment of sublingual immunotherapy for Japanese cedar pollinosis].
    Yuta A; Ogihara H; Miyamoto Y; Takeuchi K; Okubo K
    Arerugi; 2010 Nov; 59(11):1552-61. PubMed ID: 21119301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting.
    Yonekura S; Okamoto Y; Okubo K; Okawa T; Gotoh M; Suzuki H; Kakuma T; Horiguchi S; Hanazawa T; Konno A; Okuda M
    J Investig Allergol Clin Immunol; 2009; 19(3):195-203. PubMed ID: 19610262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EFFECT OF PROPHYLACTIC TREATMENT BY LEUKOTORIENE RECEPTOR ANTAGONIST ON JAPANESE CEDAR POLLINOSIS OF PRE- AND POST-SCHOOL CHILDREN JAPANESE CEDAR POLLINOSIS].
    Matsune S; Saruya S; Sawaki S; Otsuka H; Oyama Y; Minowa H; Koyama M; Ikui A; Yoshioka Y; Wakayama N; Ishida M; Sekine K; Yamaguchi S; Okubo K
    Arerugi; 2016 Feb; 65(1):57-65. PubMed ID: 26923655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylactic and therapeutic vaccines for Japanese cedar pollinosis].
    Ishii Y
    Nihon Yakurigaku Zasshi; 2010 Jun; 135(6):250-3. PubMed ID: 20543516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical Management of Japanese Cedar Pollinosis].
    Sawatsubashi M
    Fukuoka Igaku Zasshi; 2016 Jan; 107(1):1-7. PubMed ID: 27333653
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
    Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
    Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
    [No Abstract]   [Full Text] [Related]  

  • 18. Present situation of cedar pollinosis in Japan and its immune responses.
    Okamoto Y; Horiguchi S; Yamamoto H; Yonekura S; Hanazawa T
    Allergol Int; 2009 Jun; 58(2):155-62. PubMed ID: 19307773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cedar and cypress pollinosis and allergic rhinitis: quality of life effects of early intervention with leukotriene receptor antagonists.
    Sasaki K; Okamoto Y; Yonekura S; Okawa T; Horiguchi S; Chazono H; Hisamitsu M; Sakurai D; Hanazawa T; Okubo K
    Int Arch Allergy Immunol; 2009; 149(4):350-8. PubMed ID: 19295239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.
    Ogino S; Nagakura T; Okubo K; Sato N; Takahashi M; Ishikawa T
    Int Arch Allergy Immunol; 2009; 149(3):239-45. PubMed ID: 19218816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.